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Abstract
Rift Valley fever virus (RVFV) is an emerging viral zoonosis that is responsible for devastating outbreaks among livestock and
is capable of causing potentially fatal disease in humans. Studies have shown that upon infection, certain viruses have the
capability of utilizing particular cellular signaling pathways to propagate viral infection. Activation of p53 is important for
the DNA damage signaling cascade, initiation of apoptosis, cell cycle arrest and transcriptional regulation of multiple genes.
The current study focuses on the role of p53 signaling in RVFV infection and viral replication. These results show an up-
regulation of p53 phosphorylation at several serine sites after RVFV MP-12 infection that is highly dependent on the viral
protein NSs. qRT-PCR data showed a transcriptional up-regulation of several p53 targeted genes involved in cell cycle and
apoptosis regulation following RVFV infection. Cell viability assays demonstrate that loss of p53 results in less RVFV induced
cell death. Furthermore, decreased viral titers in p53 null cells indicate that RVFV utilizes p53 to enhance viral production.
Collectively, these experiments indicate that the p53 signaling pathway is utilized during RVFV infection to induce cell death
and increase viral production.
Citation: Austin D, Baer A, Lundberg L, Shafagati N, Schoonmaker A, et al. (2012) p53 Activation following Rift Valley Fever Virus Infection Contributes to Cell
Death and Viral Production. PLoS ONE 7(5): e36327. doi:10.1371/journal.pone.0036327
Editor: Tetsuro Ikegami, The University of Texas Medical Branch, United States of America
Received December 15, 2011; Accepted March 30, 2012; Published May 4, 2012
Copyright:  2012 Austin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the USA Department of Energy grant DE-FC52-04NA25455 (to CB). The funders had no role in study design, data collection
and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: KK and FK are academic editors for PLoS ONE. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data and
materials.
* E-mail: kkehnhal@gmu.edu
. These authors contributed equally to this work.
Introduction
Rift Valley fever virus (RVFV) is a Phlebovirus in the family
Bunyaviridae that is transmitted primarily by mosquitoes and is
emerging as a serious viral zoonosis affecting both livestock and
humans. RVFV remains endemic in sub-Saharan Africa and has
caused major outbreaks throughout Africa in the last century and
recently in parts of the Arabic peninsula [1,2,3]. In animals, it is
usually transmitted through the bite of a mosquito. Transmission
to humans mainly occurs through close contact with infected
animal tissue or body fluids as well as through aerosolization [3,4].
In humans, it typically causes an acute mild febrile illness
resembling the flu. However, in a small percentage of patients it
results in serious clinical manifestations such as retinal lesions,
meningoencephalitis, hepatitis, severe hemorrhagic fever, and
death [1,2,3]. In livestock, RVFV causes vast economic devasta-
tion through both mortality of adult animals as well as an
extremely high rate of abortion and fetal deformities [5]. Of
particular concern are recent epidemiological surveys of RVFV
outbreaks in humans that have shown a higher percentage of
mortality among infected individuals, increasing from 2% to 45%,
suggesting the virus could be evolving mechanisms of increased
virulence and greater pathogenicity [6].
Not unlike other bunyaviruses in its family, RVFV is a single
stranded RNA virus with a tri-segmented genome; the large (L)
segment, Medium (M) segment and Small (S) segment [1]. The
viral RNA dependent RNA polymerase (L protein) is encoded on
the L segment [7], while the M segment codes for the precursor for
two glycoproteins, Gc and Gn, as well as the nonstructural
proteins, NSm (NSm2), 78 kDa (NSm1), and 73–75 kDa (NSm2-
Gn) [8,9,10,11]. The S segment codes for one structural protein,
the nucleocapsid protein, N, and a nonstructural protein called
NSs [12]. The nonstructural proteins are not essential for
replication of the virus; however they do play a significant role
in the pathogenesis of the disease in vivo [4]. NSs protein has been
established as a virulence factor due to its ability to suppress the
host’s immune response by counteracting the antiviral interferon
(IFN) response [13,14,15,16]. NSm has also been described as a
virulence factor through anti-apoptotic functions by blocking
caspase-3 and its downstream effectors, as well as initiator
caspases, caspase-8 and 9 [17].
Our previous studies using reverse-phase protein microarray
analysis (RPMA) indicated that p53 was phosphorylated on two
residues, Ser15 and Ser46 upon infection with the virulent strain of
RVFV (ZH-501) [18]. This indicates that the p53 pathway may be
activated upon infection with RVFV. The p53 tumor suppressor
protein is activated in response to genomic stress, such as DNA
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36327damage, and has been implicated in governing many cellular
processes such as cellular homeostasis, apoptosis, cell cycle arrest,
activation of DNA repair, and cellular senescence. p53 can achieve
these functions due to its role as a transcription factor, inducing or
repressing numerous target genes. p53 can also act in a non-
transcriptional manner through direct protein-protein interaction
[19]. When bound to murine double minute 2 (MDM2), its
negative regulator, p53 is targeted for degradation by the
proteosome. However, when genomic stress occurs, several post-
translational modifications occur, including heavy phosphorylation
of the N-terminus, that help to stabilize p53 and lead to its
accumulation. Phosphorylation can be initiated by DNA damage
response (DDR) protein kinases such as Ataxia-Telangiectasia
Mutated (ATM), ATM and Rad3-related protein (ATR), Check-
point Kinase 1 (chk1) and Checkpoint Kinase 2 (chk2) [20]. The
N-terminus contains the trans-activation domain (TAD), respon-
sible for the transcriptional regulation of the protein, and the C-
terminal domain of the protein is important for specific DNA
binding of p53 [21]. The phosphorylation at specific sites can
control the activity of the protein, either through its accumulation,
activity in the TAD, or through modulation of DNA consensus
sequences affinity [22]. The serine residues located in the TAD
(Ser9, 15, 20, and 37) are important for the transcriptional
regulation of the protein. Phosphorylation of Ser15 and Ser37 are
also important for the stability of the protein. Ser20 phosphory-
lation can enhance tetramerization, stability, and activity [23].
Ser46 has been implicated in the induction of apoptosis through
the transcriptional regulation of p53AIP1 (p53 regulated apoptosis
inducing protein 1) [24]. Phosphorylation of the C-terminal end of
the p53 protein is important for sequence specific DNA binding
regulation, oligomerization state, nuclear localization and export,
as well as ubiqutination of the protein [25]. Phosphorylation at
Ser392, located in the C-terminus affects growth arrest, DNA
binding and transcriptional activation [26]. The differential
response to p53 phosphorylation is responsible, in part, for the
multifunctional nature of the protein.
p53 acts as a transcription factor to induce the regulation of
multiple genes. In doing so, p53 can control many different
cellular responses to stressors such as DNA damage. Transcrip-
tional targets of p53 regulating cell cycle arrest include 14-3-3s,
p21 and Reprimo. p21 regulates the progression of cells in the G1
phase of the cell cycle through binding to and inhibiting the
activity of CDK2 and CDK4. Activation of p21 by p53 leads to
G1 cell cycle arrest [27]. p53 regulation of DNA damage repair
induces the transcriptional targets Growth Arrest and DNA
Damage Inducible 45 (GADD45) and Proliferating Cell Nuclear
Antigen (PCNA), among others. The apoptotic pathway regulated
by p53 is activated through two major pathways, the extrinsic and
the intrinsic pathways and through both transcription dependent
as well as independent mechanisms [28]. The intrinsic pathway is
reliant on the activation of Bcl-2 family members, comprised of
both pro-apoptotic (Bid, Bax, Puma and Noxa) and anti-apoptotic
proteins (Bcl-Xl), which control the release of cytochrome c from
the mitochondria [29]. p53 induces the expression of many of the
Bcl-2 pro-apoptotic family members, activating the intrinsic
apoptotic mitochondrial pathway and promoting cell death.
The host’s response to a viral pathogen plays an important role
in the outcome of the infection. Viruses have been shown to utilize
host cellular signaling pathways to facilitate infection and viral
replication [30,31,32]. We have previously shown that p53 was
phosphorylated on Ser15 and Ser46 following infection with
RVFV ZH-501 [18]. Here we expand upon that data to
characterize additional phosphorylation events on p53. We find
that numerous Ser residues are phosphorylated following RVFV
infection and that these events are highly dependent on NSs. p53
transcriptional targets were examined and the apoptotic gene,
Noxa, was most highly upregulated following RVFV infection.
Interestingly, p53 null cells were resistant to RVFV induced cell
death and were not as efficient at viral production. These data
suggests that RVFV utilizes the p53 pathway to facilitate viral
production, possibly through the manipulation of the p53
dependent apoptotic pathway.
Materials and Methods
Cell Culture
Human small airway lung epithelial cells (HSAECs) were
obtained from Cambrex Inc., Walkersville, MD and maintained
in Ham’s F12 medium and supplemented with 1% penicillin/
streptomycin, 1% L-glutamine, 1% nonessential amino acids, 1%
sodiumpyruvate,0.001%of55 mMb-mercaptoethanol(GibcoCat
#2195-023)and10%FetalBovineSerum(FBS).Verocells(ATCC
Cat # CCL-81), MDA-MB-231 human breast cancer cells (ATCC
Cat # HTB-26) and MCF-7 human breast adenocarcinoma cells
(ATCC Cat # HTB-22) were maintained in Dulbecco’s modified
minimumessentialmedium(DMEM)supplementedwith10%FBS,
1%penicillin/streptomycinand1%L-glutamine.T47D(ATCCcat
#HTB-133)cellsweremaintainedinRPMImediumsupplemented
with 10% FBS, 1% penicillin/streptomycin and 1% L-glutamine.
A549(ATCCCat#CCL-185)cellsweremaintainedinHam’sF12
medium supplemented with 10% FBS, 1% penicillin/streptomycin
and 1% L-glutamine. HCT-116 human cancer cells and p53
heterozygous and null derivatives (p53+/+, p53+/2 and p532/2)
were maintained in McCoys 5A medium supplemented with 10%
FBS,1%penicillin/streptomycin and1%L-glutamine. Allcelllines
were maintained in 5% CO
2 at 37uC and in accordance with the
distributor’s guidelines.
Viruses
The MP-12 strain of RVFV, a live attenuated virus (LAV)
derivative of the ZH548 strain, was isolated from a patient with
uncomplicated RVFV infection in 1977. MP-12 was generated by
12 serial passages in MRC5 cells in the presence of 5-fluorouracil,
which induced a total of 25 nucleotide changes across the three
viral genome segments [33]. arMP-12-del21/384 (herein referred
to as arMP-12 DNSm) has a large deletion in the pre-Gn region of
the M segment and as a result does not express NSm, 78 kDa,
75 kDa, or 73 kDa proteins encoded by this region [9]. rMP-12-
NSdel (herein referred to as rMP-12 DNSs) completely lacks the
NSs ORF [34]. rMP-12 that has a C-terminal Flag-tagged NSs
inserted in place of the NSs ORF is referred to as rMP-12-NSs-
Flag [35].
Viral Infection
For experiments using RVFV MP-12 strain, cells were cultured
at a density of 1610
6 per well in 6-well plates. Cultured cells were
infected with MP-12 (attenuated strain of ZH548), rMP-12DNSs
or arMP-12DNSm viruses at the specified multiplicity of infection
(MOI). Cells were infected by overlaying a 400 ml suspension of
viral media on the cells and incubating them for 1 hour at 37uCa t
5% CO2. Following the 1 hour incubation, the viral media was
removed and the cells were washed with phosphate buffered saline
(PBS) without Mg and Ca and replaced with 2 ml of cell specific
media. For cell viability assay infections, cells were plated at
2.5610
4 in a 96 well plate. The same procedure as described
above was used except a 25 ml suspension of viral media is used
and 200 ml of cell specific media is replaced after 1 hour
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CO2 until appropriate collection time.
Western Blot Analysis
Cells were collected in lysis buffer: 1:1 mixture of T-PER
reagent (Pierce, IL), 26 Tris-glycine SDS sample buffer (Novex,
Invitrogen), 33 mM DTT, and protease and phosphatase inhibitor
cocktail (16Halt cocktail, Pierce)] and boiled for 10 min. Twenty-
five ml of cell lysates were separated on NuPAGE 4–12% Bis-Tris
gels (Invitrogen) and transferred to nitrocellulose or PVDF
membranes using the iBlot Gel Transfer apparatus (Invitrogen)
or either an overnight wet transfer at 70 mA or a 2 hr wet transfer
at 250 mA at 4uC. The membranes were blocked with previously
boiled 3% dry nonfat milk solution in 16 PBS +0.1% Tween
(PBS-T) for 1 hour at either room temperature or 4uC. The
primary antibodies were diluted in 3% milk solution at a 1:1000
dilution (with the exception of b-actin, 1:10,000 dilution) and
incubated overnight at 4uC. The membranes were then washed 3
times with PBS-T and incubated with secondary HRP-coupled
goat anti-rabbit and anti-mouse antibody diluted 1:10,000 in 3%
milk for 2 hours and then washed 5 times with PBS-T, 10 min
washes. The primary antibodies used were: anti-p53 (cat #9282,
Cell Signaling), anti-phospho-p53 Antibody Sampler Kit (Cat
#9919, Cell Signaling), HRP conjugated b-actin (Cat# ab49900-
100, Abcam), and anti-RVFV N (kind gift from Dr. Connie
Schmaljohn, USAMRIID). The western blots were visualized by
chemiluminescence using SuperSignal West Femto Maximum
Sensitivity Substrate kit (ThermoScientific) and a Bio Rad
Molecular Imager ChemiDoc XRS system (Bio-Rad).
Creation of Nuclear and Cytoplasmic Extracts
One million cells were resupended in 80 ml of Buffer A (10 mM
KCl, 10 mM MgCl2, 10 mM HEPES, 1 mM EDTA, 1 mM
DTT, 0.1% PMSF and EDTA-free complete protease inhibitor
cocktail) with 0.5% NP-40, and incubated for 10 minutes on ice.
Nuclei were centrifuged at 5,000 g for 5 minutes and the
supernatant saved as the cytoplasmic extract (CE) for further
analysis. Next, the nuclei were washed one time with 200 mlo f
Buffer A with 0.5% NP-40 and the centrifugation step repeated.
The nuclei were then resuspended in 80 ml of Buffer B (450 mM
NaCl, 1.5 mM MgCl2, 20 mM HEPES, 0.5 mM EDTA, 1 mM
DTT, 0.1% PMSF and EDTA-free complete protease inhibitor
cocktail) and incubated on ice for 10 minutes. Finally, lysates were
centrifuged at 20,000 g for 10 minutes and the nuclear extract
found in the supernatant saved for further analysis.
Immunofluorescent Staining
HSAEC’s cells were grown on coverslips in a 6-well plate,
infected with MP-12 as described above and washed with ice cold
PBS (without Ca and Mg) then fixed with 4% formaldehyde. Cells
where permeabilized with 0.5% Triton X-100 in PBS for 20
minutes and then washed 2 times in PBS. The cells were then
blocked for 10 minutes at room temperature in 3% BSA in PBS.
Primary antibodies anti-p53 (Cat# 9282, Cell Signaling), anti-
RVFV N protein, anti-Flag (Sigma) diluted 1:1000, was incubated
in fresh blocking buffer at 37uC for 1 hour and washed 3 times for
3 min in 300 mM NaCl with 0.1% Triton X-100. Alexa Fluor 568
anti rabbit (Cat# A10042 Invitrogen) and Alexa Fluor 488 anti
mouse (Cat# A11001 Invitrogen) dilution 1:200, were used as a
secondary antibodies and treated in the same manner as the
primary antibody. DAPI, dilution 1:1000, was used to visualize
nuclei. Fluorescence microscopy was carried out using a Nikon
Eclipse 90i microscope.
Cell Viability Assay
Cells were cultured and infected as previously described at the
indicated MOI. At the appropriate time point a cell viability assay
using CellTiter-Glo Cell Luminescent Viability Assay (Promega)
was performed according to manufacturer’s protocol. Briefly, an
equal volume of room temperature media and CellTiter-Glo
reagent was added to the cells. The plate was shaken for 2 min on
an orbital shaker and after a 10 minute room temperature
incubation; the luminescence was detected using the DTX 880
multimode detector (Beckman Coulter).
Plaque Assay
Supernatants were collected from the p53+/+ and p532/2 cell
viability experiment at the 96 hr time point from the MOI of 0.1
and 5.0 samples and stored at 280uC. Vero cells were plated in 6
well plates at 1610
6 cells per well. When cells reached 90% to
100% confluency, they were infected as follows in duplicates for
each dilution. Viral supernatants are diluted 1:10 in complete
DMEM media from 10
21 to 10
28. Four hundred ml of each viral
dilution was added to the cells. After the one hour infection an
overlay of 3 ml of a 1:1 solution of 0.5% agarose in diH20 with 26
EMEM for plaque assays, containing 5% FBS, 1% L-Glutamine,
2% penicillin/streptomycin, 1% nonessential amino acids, and 1%
sodium pyruvate was added to each well, allowed to solidify and
incubated at 37uCa t5 %C O 2 for 72 hrs. After 72 hrs, cells were
fixed using 4% formaldehyde for 1 hr at room temperature. The
agar plugs were then discarded and fixed cellular monolayers were
stained with a 1% crystal violet, 20% methanol solution for
15 min, visualizing plaques. Averages were taken from duplicates,
with dilutions containing fewer than 5 or more than 100 plaques
being discounted. The viral titer was calculated as follows: pfu/ml
= average of 2 plaque counts 62.5 (dilution factor) 6dilution.
Quantitative RT-PCR
HSAEC cells were grown in 6 well plates and infected with MP-
12 at an MOI 3.0 as described above. The cells were harvested at
24 and 48 hours P.I. in 350 ml of Buffer RLT + b-mercaptoeth-
anol. The RNA was extracted using RNeasy Mini Kit (Qiagen) in
accordance with manufacturer’s protocol. The RNA was DNAse
treated (DNase I-RNase-Free, Ambion) to remove any contam-
inating DNA. Two hundred ng of total RNA was used in a twenty
ml cDNA reaction using the iScript Select cDNA Synthesis kit
(BIO-RAD) in accordance with manufacturer’s protocol. For q-
PCR, the template cDNA was added to a 20 ml reaction with
SYBRH GREEN PCR master mix (Applied Biosystems) and
0.2 mM of primer. Refer to Table 1 for primer sequences. cDNA
was amplified (1 cycle 295uC for 10 min, 40 cycles- 95uC for
15 sec and 60uC for 1 min) using the ABI Prism 7000. Fold
changes were calculated relative to Actin using the DDCt method.
Results
p53 is Phosphorylated on Several Residues Following
Infection with RVFV
Phosphorylation plays a role in regulating many signaling
pathways. In response to DNA damage and stress stimuli, a series
of phosphorylation events take place, mainly on the N-terminus,
that contributes to the activation of p53 [25]. In addition, there are
a series of other specific serine sites of p53 within the TAD that
have been shown to regulate the activation of p53 in a specific
manner [36]. Previous studies have shown that p53 Ser15
phosphorylation is up-regulated upon infection with the RVFV
ZH-501 strain at low MOIs [18]. We were interested in
determining if additional p53 serine residues were phosphorylated
p53 in Rift Valley Fever Virus Infected Cells
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Ser15 and Ser46 phosphorylation following infection with the live
attenuated vaccine strain of RVFV, MP-12. Results in Figure 1A
indicate that both residues were phosphorylated following MP-12
infection, indicating that the attenuated virus was performing
similarly to the virulent virus. In addition, our data indicated that
RVFV MP-12 infection induces phosphorylation of all p53 serine
sites examined. Residues Ser9, Ser20, Ser37, Ser15 were highly
phosphorylated beginning at 24 hours, whereas Ser46 was not
highly phosphorylated until 48 hours (Figure 1A). p53 Ser46 has
been implicated in the induction of apoptosis [24]; therefore the
delayed response could contribute to MP-12 induced apoptosis.
p53 Ser392, a residue known to contribute to both transcription
activation and DNA binding [26], was also phosphorylated in a
manner similar to that seen with N-terminal residues (Figure 1B).
Upon activation, reduced interaction between p53 and its negative
regulator MDM2 leads to accumulation of p53 where it is then
stabilized [37]. In agreement with this model, total p53
accumulation is apparent 24 and 48 hours post infection
(Figure 1B), coinciding with the phosphorylation pattern seen at
multiple serine sites of p53. RVFV nucleoprotein (N) expression
was also monitored following infection (Figure 1C). As controls,
the phosphorylation of p53 was assessed following infection with
UV inactivated MP-12 and following doxorubicin treatment
(Figure 1D). Doxorubicin treatment resulted in the phosphoryla-
tion of p53 on all residues examined. In contrast, we did not
observed phosphorylation or stabilization of p53 following
infection with UV inactivated MP-12. Collectively, these results
demonstrate that in response to RVFV infection, p53 is
phosphorylated on multiple serine residues, both in the N-terminal
and C-terminal.
p53 Localizes to the Nucleus Following Infection with
RVFV
In normal unstressed cells p53 is present in low amounts. This is
due in part to its ubiquitination at the C-terminal end by its
negative regulator MDM2 and its export from the nucleus to the
cytoplasm where it is degraded by the proteosome [38]. When
cells are stressed, p53 accumulates in the nucleus where it can
regulate its transcriptional targets [38] to induce events such as
apoptosis and cell cycle arrest. To visualize the distribution of p53
upon infection with RVFV, HSAECs were either mock infected or
infected with MP-12 (MOI 3.0) and collected 24 hours later. p53
was visualized after the cells were immunostained with anti-p53
and Alexa fluor 568 secondary antibody (red) via confocal
microscopy. The N protein of RVFV was visualized after staining
the cells with anti-N RVFV protein and Alexa fluor 488 secondary
antibodies (green). The nucleus was visualized by DAPI staining
(blue). Figure 2 shows that in uninfected cells, p53 expression is
low and appears evenly distributed throughout the cytoplasm with
only basal levels seen in the nucleus. Upon infection with MP-12
(visualized with the RVFV N protein), p53 expression is increased
overall and p53 localizes within the nucleus with slight distribution
within the cytoplasm. Interestingly, the nuclear p53 correlated
with RVFV infection, as detected by RVFV N. To confirm these
results, nuclear and cytoplasmic extracts were analyzed for the
expression of p53 in mock or MP-12 infected cells (Figure 2B).
Lamin and GAPDH western blot analysis confirmed the purity of
the fractions. Following MP-12 infection, p53 was found
predominantly in the nucleus (compare lanes 2 and 4). These
results show that MP-12 infection induces p53 nuclear localiza-
tion, presumably where it can regulate its transcriptional targets.
p53 Phosphorylation is Highly Dependent Upon the Viral
Protein NSs
Both the NSs and the NSm proteins of RVFV have been
described as virulence factors [12]. The NSs protein forms
filaments within the nucleus of infected cells and filament
formation is implicated in pathogenesis [39]. In addition, the
NSs protein has been shown to suppress the host’s immune
response [13,15,40]. The NSm protein has been described as
having anti-apoptotic functions by blocking the caspase pathway
[17]. Because of the importance of these viral proteins in the
virulence of RVFV, we wanted to determine whether they were
involved in the p53 phosphorylation events observed in Figure 1.
To this end we utilized two different viruses generated through
reverse genetics. arMP-12-del21/384 (herein referred to as arMP-
12 DNSm) has a large deletion in the pre-Gn region of the M
segment and as a result does not express NSm, 78 kDa, 75 kDa, or
73 kDa proteins encoded by this region [9]. rMP-12-NSdel (herein
referred to as rMP-12 DNSs) completely lacks the NSs ORF [34].
Vero cells were collected 24 hours after mock infection or infection
with MP-12, rMP-12 DNSs or arMP-12 DNSm. Western blot
analysis using anti-p53 total and anti-p53 Ser15 antibodies
(Figure 3A) show a very similar pattern of up-regulation with
MP-12 and arMP-12 DNSm infected cells. Ser392 phosphoryla-
tion of p53 was also increased in MP-12 and arMP-12 DNSm
infected cells at 24 hours (Figure 3B). There is a slight reduction of
p53 phosphorylation and p53 accumulation in the arMP-12
DNSm infected cells compared to the MP-12 infected cells. As
NSm is known to be anti-apoptotic, a loss of p53 signaling in
arMP-12 DNSm infected cells seems somewhat surprising.
Table 1. Primer Sequences.
Primer Pair Forward Sequence 59-39 Reverse Sequence 59-39
Bax TGC TTC AGG GTT TCA TCC AG CGC GGC AAT CAT CCT CTG
Puma GGG CCC AGA CTG TGA ATC CT ACT TGC TCT CTC TAA ACC TAT GCA
Noxa GTG CCC TGG GAA ACG GAA GA CCA GCC GCC CAG TCT AAT CA
p21 CTG GAG ACT CTC AGG GCG AAA GAT TAG GGC TTC CTC TTG GAG AA
GADD45 TGC TCA GCA AAG CCC TGA GT GCT TGG CCG CTT CGT ACA
14-3-3s GGC CAT GGA CAT CAG CAA GAA CGA AAG TGG TCT TGG CCA GAG
MDM2 GTG AAT CTA CAG GGA CGC CAT C CTG ATC CAA CCA ATC ACC TGA A
p62 TGC AGG CAC AAC TAA CTT ACT TGA CTC ACA ACA AGG TCT TT
Actin GCC GGT CGC AAT GGA ACA AGA CAT GGC CGG GGT GTT GAA GGT
doi:10.1371/journal.pone.0036327.t001
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and 73 kDa proteins which have unknown functions to date [9].
Specifically, the 78 kDa protein was unable to suppress apoptosis,
indicating that it has a function distinct from the anti-apoptotic
role of NSm [9]. These data suggest that the loss of one or more of
these proteins may have an influence on p53 signaling. In contrast,
cells infected with the rMP-12 DNSs strain, show a dramatic lack
of Ser 15 and Ser 392 phosphorylation and p53 accumulation at
24 hour. As controls for viral replication and protein expression,
western blot analysis for the N protein was performed (Figure 3B)
and the amount of released virus at 16, 24, and 48 hours post-
infection was analyzed (Figure 3C). MP-12 and rMP-12 DNSs
replicated at similar levels at all time points examined, however
arMP-12 DNSm displayed an increase in released virus as
compared to MP-12 and rMP-12 DNSs at 24 hours post-infection.
These results demonstrate a strong dependence on the NSs protein
for both the rise in p53 levels as well as the phosphorylation events
observed upon infection.
As p53 phosphorylation was dependent on NSs, we sought to
determine if NSs and p53 colocalized following RVFV infection.
To this end, HSAECs were either mock infected or infected with
MP-12 that has C-terminal Flag-tagged NSs inserted in place of
the NSs ORF (rMP-12-NSs-Flag) [35]. Cells were collected 24
hours post-infection and p53 and NSs visualized through confocal
microscopy. Figure 4 demonstrates that following rMP-12-NSs-
Flag infection, p53 expression is increased and highly nuclear in
nature, confirming the results presented in Figures 1, 2 and 3. NSs
filaments were observed in approximately 60% of all cells. Cells
with NSs filaments displayed nuclear abnormalities, such as
lobulated nuclei, as has recently been published by Mansuroglu et
al., 2010 [41]. p53 and NSs partially co-localize (white arrows) in
approximately 20% of cells visualized and this coincided with
strong p53 nuclear staining. Collectively, these results demonstrate
the increase in p53 phosphorylation and total protein levels are
dependent on NSs and that NSs and p53 partially co-localized
following RVFV infection.
RVFV Infection Induces the Up-regulation of p53
Targeted Genes
Given the function of p53 as a transcription factor, the question
arises as to whether RVFV infection results in increased p53
binding to various promoters and regulation of their transcription.
To determine if RVFV infection affects the induction of p53
transcriptional targets, quantitative RT-PCR was performed on
p53 regulated genes. The p53 target genes involved in apoptosis
that were analyzed are Bax, Puma and Noxa (Figure 5A–C). The
genes of interest known to be involved in cell cycle control that
were analyzed were GADD45, 14-3-3s, and p21 (Figure 5D–F).
In addition, the negative regulator of p53, MDM2 was analyzed
(Figure 5G). The results show that in response to RVFV infection
Figure 1. p53 is phosphorylated on several residues following infection with RVFV. A) HSAECs were either mock or MP-12 infected at an
MOI of 3.0. Cells were collected 6, 24 and 48 hours post infection and lysates were analyzed by western blotting for antibodies against p53 at the
residues indicated (Ser 9, Ser 20, Ser 37, Ser 46 and Ser 15). B) HSAECs infected in the same manner as Fig. 1A were collected at the time points
indicated and analyzed by western blotting for antibodies against total p53 and p53 (Ser392). C) HSAECs were treated in the same manner as Fig. 1A
and Fig. 1B and analyzed by western blotting for antibodies against the N protein of RVFV. D) HSAECs were infected with UV inactivated MP-12 (MOI
3.0) and collected at 24 and 48 hours post-infection. In parallel, HSAECs were treated with doxorubicin (1 mM) and collected at 24 hours. Cell lysates
were analyzed by western blot analysis as describe in panels A and B. Actin is used as a loading control in all panels.
doi:10.1371/journal.pone.0036327.g001
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Of the apoptotic genes, Noxa displayed the greatest fold induction
(almost 10 fold) as compared to the mock infected cells. Neither
Puma nor Bax demonstrated changes greater than 2 fold. 14-3-3s
and GADD45 were both increased by greater than 2 fold;
however, p21 transcriptional levels were not significantly altered.
MDM2 displayed an increase of almost 5 fold, further supporting
the observed p53 stabilization and accumulation following RVFV
infection. p62 expression was used as a control for transcription
since RVFV infection was recently found to induce p62
downregulation post-transcriptionally [42]. As has been previously
reported, p62 transcription was not altered following RVFV
infection (Figure 5H). These results indicate that transcriptional
targets of p53 involved in the apoptotic pathway and cell cycle
control are increased following RVFV infection, with Noxa being
significantly up-regulated.
Loss of p53 Results in Decreased RVFV Induced Death
Having characterized p53 as being activated following infection
with RVFV and Noxa as the most significantly up-regulated p53
target, we next sought to determine the influence of p53 on RVFV
induced cell death. For this, we utilized two p53 wild-type (WT),
A549 and MCF-7, and two p53 mutant (mt), MDA-MB-231 and
T47D, cell lines. The mt cell lines are breast cancer cells which
have high levels of mutated p53, mutated in the DNA binding
region. Cells were mock infected or infected with MP-12 (MOI 0.1
and 1.0) and cell viability assessed at 48 hours and 72 hours post
infection. At 48 hours post infection there was little to no loss of
viability in the p53 mt cells, whereas the p53 WT cells displayed
an MOI dependent loss in viability (Figure S1A). By 72 hours, p53
mt cells began to display a decrease in cell viability, but still to a
lesser extent than that of the p53 WT cells (Figure S1B). These
results demonstrate that p53 WT status results in a greater loss of
cell viability following RVFV infection.
To further characterize p53 as having a role in decreased cell
viability following infection by RVFV, we obtained HCT-116 cells
completely devoid of p53 (p532/2, null) as well as the WT
(p53+/+) and heterozygous (p53+/2) counterparts. Cell viability
assays were performed on each of the cell lines 96 hours after mock
infection or infection with MP-12 at the indicated MOIs. The
results are analogous to those obtained for the mutant cells lines.
Particularly at the higher MOIs (MOI 0.5–5.0), the p53 null cells
showed increased survival compared to the WT cell line after
Figure 2. p53 localizes to the nucleus following infection with RVFV. A) HSAECs were either mock infected or infected with MP-12 (MOI 3.0).
At 24 hours post infection the cells were washed in PBS without Ca and Mg, permeabilized with Triton X-100 and immunostained with anti-p53
primary antibody using Alexa-Fluor 568 secondary antibody and with anti-RVFV N protein antibody using Alexa-Fluor 488 secondary antibody. The
nucleus was stained with DAPI. B) HSAECs were mock infected or infected with MP-12 (MOI 3.0) and collected at 24 hours post-infection for the
creation of cytoplasmic and nuclear extracts, CE and NE. Western blot analysis was performed with antibodies against lamin, GAPDH, total p53 and
RVFV N protein.
doi:10.1371/journal.pone.0036327.g002
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line (p53+/2) show an intermediate increase in cell viability under
the same conditions. Figure 6B confirms through western blot
analysis that the expression of p53 in the p53 null cells is absent,
while the heterozygous cells show less p53 protein than the WT
p53 cells. It is interesting to note that the HCT-116 cells appear to
be inherently resistant to RVFV induced cell death, as at 96 hours
post-infection, 50% viability remained. Confocal microscopy
imaging of RVFV N protein indicated that only around 10% of
all cells were infected at 96 hours (data not shown). It is likely that
Figure 3. p53 phosphorylation following RVFV infection is NSs dependent. A) Vero cells were either mock infected or infected with MP-12,
rMP-12 DNSs or arMP-12 DNSm viruses at an MOI of 3.0. Cells were collected 24 hours post infection and western blot analysis was performed on the
cell lysates using antibodies against p53 (Ser15) and total p53. B) Cells were infected and processed as described in panel A. Western blot analysis was
performed for p53 (Ser20), and the N protein of RVFV. Actin was used as a loading control. C) Vero cells were infected with MP-12, rMP-12 DNSs or
arMP-12 DNSm viruses at an MOI of 3.0. Viral supernatants were collected at 16, 24 and 48 hours post-infection and released virus determined by
plaque assays. (*) indicates statistically significant difference (unpaired t-test) p,0.001. Error bars indicate standard deviation.
doi:10.1371/journal.pone.0036327.g003
Figure 4. p53 partial co-localizes with RVFV NSs. A) HSAECs were either mock infected or infected with rMP-12-NSs-Flag (MOI 3.0). At 24 hours
post infection the cells were washed in PBS without Ca and Mg, permeabilized with Triton X-100 and immunostained with anti-p53 primary antibody
using Alexa-Fluor 568 secondary antibody and anti-Flag protein antibody using Alexa-Fluor 488 secondary antibody. The nucleus was stained with
DAPI. Arrows indicate NSs Filaments and areas of p53/NSs colocalization.
doi:10.1371/journal.pone.0036327.g004
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and the cells that remain are largely uninfected.
We sought to confirm these findings in a cell line that is more
susceptible to RVFV induced cell death. To this end, HSAECs
were infected with MP-12 at various MOIs (1, 3, 10) and cell
viability accessed at 48 and 72 hours post-infection (Figure 6C). At
72 hours and a MOI of 10, only 39% of cells remained viable.
Therefore, this time point was chosen to examine the influence of
p53 siRNA mediated knockdown on RVFV induced cell death. A
titration of negative control siRNA (siNEG) or p53 siRNA (sip53)
was performed to determine the optimal concentration of siRNA
to be utilized. All three concentrations of siRNA (50, 100, 200 nM)
resulted in a loss of p53 protein expression (Figure 6D). The mid
concentration (100 nM) was chosen for additional experiments as
it was effective at reducing p53 protein levels and the higher
concentration of 200 nM did not reduce p53 levels further at 48
hours post-transfection. Next, cell viability was assessed 72 hours
following MP-12 infection in cells that were transfected with
siNEG or sip53. Loss of p53 through siRNA knockdown resulted
in significantly less cell death following RVFV infection
(Figure 6E). These results demonstrate a direct correlation
between loss of p53 function and a greater resistance to RVFV
induced cell death, suggesting that p53 plays a role in RVFV
induced apoptosis.
RVFV Production is Decreased in p53 Null Cells
Next, we assessed the amount of viral production in the
presence or absence of p53. Plaque assays were performed using
viral supernatants collected at 96 hours from the p53 WT (p53+/
+) and p53 null (p532/2) cells infected with MP-12 (MOI 0.1 and
5.0). The p53 null cells showed an average viral titer of
3.9610
6 pfu/ml at an MOI of 0.1 (Figure 7). This is decreased
more than a log as compared to the viral titers of 6.1610
7 pfu/ml
obtained from the p53 WT cells. At the higher MOI (5.0), the
decrease in viral titer was more dramatic in the p53 null cells with
nearly a two log difference compared to the p53 WT cells. These
results demonstrate that lack of p53 results in less RVFV being
produced.
Discussion
Like all viruses, RVFV employs the host’s cellular machinery to
complete its lifecycle. Identifying particular host cellular networks
that aid in viral propagation is important for further understanding
of the viral lifecycle as well as in the development of novel
therapeutics to combat infection. Given the importance of p53 in
the regulation of many cellular processes such as growth arrest,
DNA damage repair, and apoptosis, it would seem logical that
Figure 5. RVFV infection induces the Up-regulation of p53 target genes. HSAECs were either mock infected or infected with MP-12 (MOI
3.0). Cells were collected at 24 hours post infection. RNA was extracted using Qiagen’s RNeasy Mini Kit. After cDNA synthesis, qRT-PCR was performed
on the samples using the primers shown (Bax, Puma, Noxa, GADD45, 14-3-3s, p21, MDM2 and p62) (Panels A–H). Actin was used to normalize the
samples. (*) indicates statistically significant difference (unpaired t-test of triplicates) p,0.05. Error bars indicate standard deviation.
doi:10.1371/journal.pone.0036327.g005
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pathways for its benefit.
The activation of the p53 pathway following RVFV infection is
evident in the consistently up-regulated phosphorylation observed
at every serine phosphorylation site examined, both in the TAD
and the C-terminal domain. This universal phosphorylation is
interesting given the specific functions each residue seems to
exhibit. As previously mentioned, Ser15 and Ser20 are important
in the activation and stability of p53, while Ser46 plays a role in
apoptosis. Ser392, located in the C-terminal domain, is important
for DNA binding and transcriptional activation and is also highly
phosphorylated. In addition to the individuality of each residue’s
function, is the fact that these residues can be phosphorylated by
several different kinases [36]. Recent work from our laboratory
indicates that RVFV infection causes opposing activation of ATM
and ATR pathways, where ATM and chk2 phosphorylation are
up-regulated at 24 hours post-infection, whereas ATR phosphor-
ylation is down-regulated [43]. These data indicated that following
RVFV infection, the p53 pathway may be at least partially
activated through an ATM-chk2 specific signaling cascade;
however, there are likely additional upstream kinases contributing
to the robust p53 phosphorylation. ATM and chk2 activation
following RVFV were shown to be responsible for the RVFV
induced S phase arrest [43]. Cell cycle arrest can be transient to
provide time for the cell to repair itself prior to proceeding into the
next phase of the cell cycle or if the insult is considered too great
(as in the case of RVFV infection), apoptosis can be initiated.
Although apoptosis can be initiated through other mechanisms,
phosphorylation of p53 at Ser46 is considered to be a primary
determinant of apoptotic induction through the p53 pathway [44].
Figure 6. Loss of p53 provides resistance to RVFV induced cell death. A) HCT-116 p53+/+, +/2, and 2/2 cells were mock infected or
infected with MP-12 (MOI 0.1, 0.5, 1.0, and 5.0). Cell viability was determined 96 hours post-infection by CellTiter-Glo Assay (Promega). Viability of the
infected cells was calculated relative to the mock infected cells (100%) (average of triplicates shown). (*) Indicates statistically significant difference
(unpaired t-test of triplicates) p,0.05. Error bars indicate standard deviation. B) Western blot analysis of uninfected whole cell lysates from HCT-116
p53+/+, +/2, and 2/2 cells probed with anti-p53 total and actin antibodies. C) HSAECs were either mock infected or infected with MP-12 (MOI 1, 3,
or 10). Cell viability was determined 48 and 72 hours post-infection by CellTiter-Glo Assay (Promega). Viability of the infected cells was calculated
relative to the mock infected cells (100%) (average of triplicates shown). D) HSAECs were transfected with negative control siRNA (siNEG) or siRNA
targeting p53 (sip53) at 50, 100, or 200 nM using attractene’s fast-forward method. Twenty-four hours post-transfection, cells were infected with MP-
12 and collected 24 hours post-infection. Cell lysates were analyzed by western blot analysis for total p53 and actin. Lane 1 is a mock infected and
untransfected control. E) HSAECs were transfected with siNEG or sip53 (100 nM) by attractene’s fast-forward method. Twenty-four hours post-
transfection cells were mock infected or infected with MP-12 (MOI 10). Cell viability was determined 72 hours post-infection by CellTiter-Glo Assay
(Promega). Viability of the infected cells was calculated relative to the mock infected cells (100%) (average of triplicates shown). (*) Indicates
statistically significant difference (unpaired t-test of triplicates) p,0.01. Error bars indicate standard deviation.
doi:10.1371/journal.pone.0036327.g006
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until 48 hours post infection, when apoptotic signaling occurs in
HSAECs [45]. Specifically, we have previously shown that in
HSAECs, even at a relatively low MOI (0.002) at 48 hours post
infection, RVFV causes an increase in effector caspases 3, 6 and 7
and an increase in the sub G1 population, indicative of apoptosis
[18]. In addition, our studies indicate that loss of p53 results in cell
being more resistant to RVFV induced cell death. Given the
importance of the NSs protein in the virulence of RVFV, it is not
surprising that the phosphorylation of at least two residues of p53
(Ser15 and Ser392), as well as total p53 accumulation within the
cell, are dependent on NSs. NSs localizes to the nucleus forming
large filaments, which are responsible for a high incidence of
nuclear anomalies and known chromosome cohesion and segre-
gation defects [41]. Based on these properties, it would be
plausible that NSs dependent DNA damage is occurring and
contributing to the activation of p53 through the DDR pathway.
However, our recently published work indicated that RVFV
infection does not induce DNA damage [43], as expected. Our
data also demonstrated a partial co-localization of NSs and p53
specifically on NSs filaments. Current studies are investigating the
possibility of NSs interacting with p53 directly or as part of a larger
protein complex present on NSs filaments. It is also possible that
NSs is not interacting with p53, but rather acting in conjunction
with other host proteins upstream of p53 to induce p53
phosphorylation and stabilization.
Our quantitative RT-PCR results show a general up-regulation
of p53 transcriptional targets upon infection with RVFV. This is
interesting considering that the NSs protein of RVFV has been
shown to target the general transcription factor TFIIH to suppress
host transcription [46]. Specifically, NSs can interact with the p44
subunit of TFIIH at specific sites to form filaments and reduce
levels of the p62 subunit of TFIIH [42]. While these proteins are
reduced, they are not completely degraded upon infection with
RVFV and may allow for transcriptional activation of selected
genes. In addition, the p53 TAD interaction with the p62 subunit
was shown to be enhanced by phosphorylation at Ser46 of p53
[47]. Given that Ser46 phosphorylation is up-regulated upon
infection, perhaps this increased affinity for p62 could compensate
for the reduced levels of p62. p53 also interacts with TFIID,
another basal transcription factor, providing another potential
mechanism for p53 regulated transcriptional activation [48].
The manipulation of the p53 pathway has been demonstrated in
numerous viral infections [49]. For chronic cancer causing viruses,
such as human papilloma virus (HPV) and human T-cell leukemia
virus 1 (HTLV-1), p53 inhibition by viral proteins contributes to
transformation [50,51,52,53]. Specifically the HPV E6 protein
induces the degradation of p53, while the HTLV-1 Tax protein
has multiple proposed mechanisms of p53 inactivation, including
sequestration of transcriptional cofactors CREB binding protein
(CBP) and p300 [50,51,52,53]. For acute viral infections, p53
inactivation is often times postulated as a means to subvert the
anti-viral response and/or as a mechanism to inhibit apoptosis to
allow sufficient time for efficient viral replication [49]. However,
there are viruses that cause activation of p53 to enhance their
replication. For example, West Nile Virus (WNV) capsid protein
induces nuclear accumulation of p53 and prevents it from
associating with MDM2, resulting in p53 stabilization [54]. In
WNV infected cells, the p53 transcriptional target, Bax, was up-
regulated and contributed to apoptosis [54]. Interestingly, p53 null
cells displayed decreased apoptosis and viral replication, indicating
that p53 enhances WNV replication [54]. In addition, viral
activation of p53 can lead to efficient viral release and
dissemination through promoting apoptosis [55]. Similar to
WNV infection, we observed an increase in apoptosis and RVFV
production in p53 WT cells. We hypothesize that p53 activation
by NSs is important for the induction of apoptosis and viral release
at later stages of viral infection. Conversely, RVFV NSm protein
serves an anti-apoptotic role, functioning to balance the pro-
apoptotic p53 signaling, allowing a delay in apoptosis until efficient
viral replication can proceed.
It is important to note that a recent publication by Verbruggen
et al. demonstrated a lack of p53 activation by the orthobunyavirus
La Crosse [56]. In this study, other markers of the DNA damage
response pathway, such as phosphorylation of histone H2A.X,
degradation of RNA polymerase II, and transcriptional activation
Figure 7. RVFV production is decreased in p53 null cells. HCT-116 p53+/+ and 2/2 cells were mock infected or infected at the indicated MOIs
(0.1 and 5.0). At 96 hours post infection viral supernatants were collected and cells were used in a Cell Viability Assay (Figure 4b). Plaque assays were
performed in triplicates using the supernatants and the average viral titers (pfu/ml) of the triplicates are shown. (*) Indicates statistically significant
difference (unpaired t-test of triplicates) p,0.05, or (**) p,0.01. Error bars indicate standard deviation.
doi:10.1371/journal.pone.0036327.g007
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La Crosse viral protein NSs, which has similar functions to RVFV
NSs including transcriptional inhibition and interferon antagonism
[56,57]. La Crosse NSs while being found in the nucleus does not
form filaments. RVFV infection also induces histone H2A.X
phosphorylation and a number of other classical DNA damage
responsive proteins [43]. Therefore, these recent findings indicate
a clear distinction between the host signaling induced by La Crosse
NSs and RVFV NSs, namely the modulation of the p53 pathway.
This is not entirely surprising as the two viruses have evolved
distinct mechanism to facilitate interferon antagonism [58]. These
data suggest that these viruses may also utilize distinct pathways
for the induction of apoptosis, with RVFV cell death being
influenced by p53.
The overall conclusions of this research points to a role of the
p53 pathway in the induction of RVFV induced apoptosis. Upon
infection of RVFV, p53 is activated as supported by the amplified
phosphorylation of p53 on multiple sites and the localization of
p53 within the nucleus. The lack of p53 results in a greater
resistance to RVFV induced cell death as well as a decrease in viral
production. RVFV infection corresponds to an increase in both
cell cycle regulator genes and pro-apoptotic genes of the intrinsic
apoptotic pathway controlled by p53. Further research is needed
to uncover the exact mechanism by which RVFV utilizes the p53
pathway for efficient viral production.
Supporting Information
Figure S1 p53 mutant cells are more resistant to RVFV
induced cell death. p53 WT (A549 and MCF-7) and p53 mt
(MDA-MB-231 and T47D) cells were plated at 25,000 cells per
well in a 96 well plate. Cells were mock infected or infected with
MP-12 (MOI 0.1 and 1.0). Cell viability was determined at A) 48
or B) 72 hours post-infection by CellTiter Glo Assay (Promega).
Viability of the infected cells was calculated relative to the mock
infected cells (100%) (average of triplicates shown). (*) Indicates
statistically significant difference (unpaired t-test of triplicates)
p,0.01. Error bars indicate standard deviation.
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